Stock UDJ APPLIED DNA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Applied DNA Sciences, Inc. BOERSE MUENCHEN

Equities

UDJ

US03815U4094

Market Closed - BOERSE MUENCHEN
Other stock markets
 15:44:16 2024-06-28 EDT 		5-day change 1st Jan Change
0.414 EUR 0.00% Intraday chart for Applied DNA Sciences, Inc. -0.48% -96.49%
06-20 Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics CI
06-18 Applied DNA Partners With GenXys For Pharmacogenetic Testing MT

Chart calendar Applied DNA Sciences, Inc.

c38d80bbfa9aabd9076.Etgc5mPOb4YXVcsO87qwHVFd743hwW_zpcxhjRi8B-Q.c5VWhwyjPc9BJYk6w4iBZBAVteutuAvE4bYyuCrmaZJ062izBZQ14lsi-w~e80887ed946ebb83f1134e0285816b01

Upcoming events on Applied DNA Sciences, Inc.

2024-08-07 Q3 2024 Earnings Release (Projected)
2024-12-17 Q4 2024 Earnings Release (Projected)
2025-02-05 Q1 2025 Earnings Release (Projected)
2025-05-07 Q2 2025 Earnings Release (Projected)

Past events on Applied DNA Sciences, Inc.

2024-06-12 European Hematology Association Meeting - P1722
2024-06-11 Investor Meeting
2024-05-10 16:05 Q2 2024 Earnings Release
2024-04-24 Reverse Split: 1 of 20
2024-04-15 10:00 Extraordinary Shareholders Meeting
2024-02-08 16:30 Q1 2024 Earnings Call
2024-02-08 16:05 Q1 2024 Earnings Release
2023-12-07 16:30 Q4 2023 Earnings Call
2023-12-07 16:05 Q4 2023 Earnings Release
2023-09-19 10:00 Annual General Meeting
2023-08-10 16:30 Q3 2023 Earnings Call
2023-08-10 16:05 Q3 2023 Earnings Release
2023-06-21 16:30 Maxim Group Virtual Healthcare Conference
2023-05-11 16:30 Q2 2023 Earnings Call
2023-05-11 16:05 Q2 2023 Earnings Release
2023-02-09 16:30 Q1 2023 Earnings Call
2023-02-09 16:05 Q1 2023 Earnings Release
2023-01-08 JP Morgan Healthcare Conference
2022-12-14 16:30 FY 2022 Earnings Call
2022-12-14 16:10 FY 2022 Earnings Release

Annual results

Fiscal PeriodSeptember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		5,39
5,83
-7.56%		1,93
2,33
-16.94%		9,03
8,28
8.98%		18,2
18,7
-2.91%		13,4
14,3
-6.32%
4,50

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-9,12
-8,72
-4.66%		-12,5
-11,6
-7.87%		-13,1
-11,5
-14.32%		-14,0
-12,3
-13.85%		-11,0
-10,3
-6.53%
-14,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-8,62
-8,86
2.72%		-13,0
-12,1
-7.97%		-14,3
-12,6
-13.3%		-8,27
-10,4
20.56%		-10,0
-9,91
-1.17%
-12,8

Net income
Million USD		Released
Forecast
Spread 		-8,93
-8,86
-0.84%		-13,0
-12,1
-7.96%		-14,3
-12,6
-13.33%		-8,38
-10,5
20.36%		-9,95
-9,86
-0.86%
-12,7

EPS
USD		Released
Forecast
Spread 		-194
-206
5.74%		-66,4
-61,0
-8.85%		-41,4
-37,0
-11.89%		-18,6
-23,8
21.85%		-15,2
-15,2
0%
-5,32

Announcement Date12/12/1917/12/2009/12/2114/12/2207/12/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales
Million USD		Released
Forecast
Spread 		6,15
4,50
36.64%		4,30
3,60
19.31%		3,56
4,10
-13.28%		5,26
4,17
26.22%		4,41
4,13
6.84%		2,92
2,56
14.07%		0,78
1,68
-53.6%		0,89
0,78
14.84%		0,93
0,95
-2.25%
1,08


1,60


1,20


1,40


1,60

EBIT
Million USD		Released
Forecast
Spread 		-1,99
-2,74
27.18%		-2,84
-2,89
1.83%		-4,37
-2,81
-55.77%		-1,22
-3,75
67.48%		-2,70
-2,59
-4.34%		-2,86
-3,13
8.63%		-4,17
-3,50
-19.17%		-3,79
-4,13
8.21%		-3,62
-3,61
-0.17%
-3,57


-3,32










Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-1,76
-2,76
36.2%		-1,12
-2,89
61.09%		-0,66
-2,81
76.31%		-3,84
-3,75
-2.55%		0,55
-2,59
121.27%		-3,11
-3,13
0.47%		-3,62
-3,50
-3.3%		-1,13
-4,13
72.62%		-4,49
-3,75
-19.83%
-3,57


-3,56










Net income
Million USD		Released
Forecast
Spread 		-1,87
-2,76
32.25%		-1,12
-2,89
61.11%		-0,66
-2,81
76.36%		-3,84
-3,75
-2.53%		0,59
-2,59
122.7%		-3,10
-3,13
0.93%		-3,59
-3,50
-2.64%		-1,11
-4,13
73.23%		-4,63
-3,61
-28.09%
-3,57


-3,32










EPS
USD		Released
Forecast
Spread 		-4,60
-6,67
31%		-2,60
-7,10
63.38%		0,20
-4,70
104.26%		-6,00
-5,80
-3.45%		1,00
-4,00
125%		-4,80
-4,80
0%		-5,20
-5,30
1.89%		-1,80
-6,20
70.97%		-5,31
-4,50
-18%
-0,50


-0,33


-0,35


-0,23


-0,17

Announcement Date12/05/2211/08/2214/12/2209/02/2311/05/2310/08/2307/12/2308/02/2410/05/24-----

Upcoming sector events for Applied DNA Sciences, Inc.

2024-07-17 02:00 VITROLIFE AB: Q2 2024 Earnings Release
2024-07-29 AMOY DIAGNOSTICS CO., LTD.: Q2 2024 Earnings Release (Projected)
2024-07-31 MYRIAD GENETICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 LANTHEUS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 10X GENOMICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 MACCURA BIOTECHNOLOGY CO.LTD: Q2 2024 Earnings Release (Projected)
2024-07-31 SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.: Q2 2024 Earnings Release (Projected)
2024-07-31 DIASORIN S.P.A.: Q2 2024 Earnings Release
2024-08-04 CASTLE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-08-08 SD BIOSENSOR, INC: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Applied DNA Sciences, Inc.

2024-05-15 SD BIOSENSOR, INC: Q1 2024 Earnings Release
2024-05-10 09:21 DIASORIN S.P.A.: Q1 2024 Earnings Release
2024-05-07 16:05 MYRIAD GENETICS, INC.: Q1 2024 Earnings Release
2024-05-02 16:05 CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release
2024-05-02 07:00 LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-30 16:05 10X GENOMICS, INC.: Q1 2024 Earnings Release
2024-04-29 GETEIN BIOTECH, INC: Q4 2023 Earnings Release
2024-04-29 GETEIN BIOTECH, INC: Q1 2024 Earnings Release
2024-04-29 ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release
2024-04-29 SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. APDN Stock
  4. UDJ Stock
  5. Calendar Applied DNA Sciences, Inc.